Kevin Etzkorn brings over 12 years of venture capital, operational, and technical management experience to the Fund.
Prior to joining Heron, Mr. Etzkorn was a Principal at CID Capital, a venture capital and private equity firm...
Read more about Kevin Etzkorn.
See the entire
Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. Celleration received 510K clearance from the FDA in 2005 with the full claim of "promote wound healing". Shortly thereafter, the company introduced the MIST Therapy System to the US market and has since built...
View Our Portfolio
AirXpanders Announces First Commercial U.S. Procedure for AeroForm® Tissue Expander System for Breast Reconstruction
January 18, 2017
US FDA grants de novo clearance to AirXpanders' AeroForm Tissue Expander System for breast reconstruction
December 26, 2016
First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation
November 9, 2016